Project Grant R01AI181799

Award Date 8/14/24
Completion Date 6/30/29
Dollars Obligated $911K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
This $825,988 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to leverage social determinants data and spatial data science to reduce HIV incidence in Ending the HIV Epidemic (EHE) counties across the United States. The key products and services to be delivered under this grant include: Developing transportation-based measures of PrEP accessibility at the county and zip code levels using...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,000 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Medical College of Wisconsin, Inc. on August 1, 2024. This award will fund a 3-year project to identify barriers and facilitators to implementing long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention, determine optimal implementation strategies in partnership with stakeholders, and pilot an implementation...
This Project Grant award, with a total funding amount of $667,848, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will support research to investigate the molecular and phenotypic features of pre-existing HIV gp120-specific B cells, and how these B cell populations respond to HIV vaccination in high-risk individuals, including those using pre-exposure prophylaxis (PrEP). The...
This federal Project Grant award in the amount of $2,127,639.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to develop and evaluate a multi-level integrated strategy to optimize pre-exposure prophylaxis (PrEP) adherence among Black men who have sex with men (MSM) and accelerate implementation at scale. The key components of the strategy include: The...
This federal Project Grant award, funded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), supports a participatory system dynamics study to enhance access to pre-exposure prophylaxis (PrEP) for Black and Latinx sexual minority men in the Bronx, New York. The $252,000 award, with a project period from September 1, 2024 to August 31, 2026, aims to: 1) co-design and validate a system dynamics model identifying factors influencing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $820,845 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to New York University School of Medicine. The grant will fund a collaborative research project with the Shelby County Health Department to use mathematical modeling to inform policy decisions aimed at improving HIV outcomes across diverse settings, including New York City, Memphis, and Northwest Mississippi. The research will...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $677,589 to the University of North Carolina at Chapel Hill (UNC-CH) to adapt and pilot a HIV prevention program called "FIT for PrEP (F4P)". The F4P program aims to link incarcerated women, who are at high risk for HIV acquisition, to post-release pre-exposure prophylaxis (PrEP) services and social support upon...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a randomized controlled trial to evaluate strategies for engaging the social networks of current PrEP clients from high-HIV incidence communities in Miami, Florida. The $2,155,836 award will fund a 5-year study to compare the effectiveness, cost, and implementation factors of two approaches: 1) a...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $186,840 to the University of Chicago to develop, pilot, and evaluate a multilevel intervention that combines a refined media campaign and peer-based strategy, informed by social network analysis. The goal is to increase uptake of pre-exposure prophylaxis (PrEP) among young Latino sexual minority men, a population disproportionately...
This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

This federal Project Grant award of $911,400.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will support the development of the PREMISE (PREP Epidemiology, Modeling, and Surveillance) group to utilize national PrEP (pre-exposure prophylaxis) data, along with legal and policy coding, to inform the U.S. HIV epidemic response. The project aims to conduct analyses on the scope and equity of PrEP scale-up over time, as well as explore the impact of locality-specific programs and policies on PrEP uptake and equity. Sub-awards were provided to the Regents of the University of Minnesota, Oregon Health & Science University, and the National Alliance of State & Territorial AIDS Directors to contribute specialized expertise in areas such as biomedical research, data analysis, technical assistance, and community partnerships. The grant has an award date of August 14, 2024 and an ultimate completion date of June 30, 2029.

Generated 6/10/25, 3:33 AM